(Q42734279)

6 November 2017

Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers (English)

1 reference

6 November 2017

31

1 reference

6 November 2017

36

1 reference

6 November 2017

Marka van Blitterswijk

Marka van Blitterswijk

1

0 references

Elizabeth Finger

Elizabeth Finger

11

0 references

Melissa E. Murray

Melissa E Murray

Mariely DeJesus-Hernandez

7

0 references

5

Mariely DeJesus-Hernandez

1 reference

6 November 2017

Michael J Strong

19

0 references

Charles L White

Charles L White

17

0 references

Leonard Petrucelli

24

Leonard Petrucelli

1 reference

6 November 2017

21

Zbigniew K Wszolek

1 reference

6 November 2017

18

Manuela Neumann

1 reference

6 November 2017

37

Rosa Rademakers

1 reference

6 November 2017

28

Ronald C Petersen

1 reference

6 November 2017

32

Bruce L Miller

1 reference

6 November 2017

20

Thomas G Beach

1 reference

6 November 2017

30

William W Seeley

1 reference

6 November 2017

27

David S Knopman

1 reference

6 November 2017

35

Bradley F Boeve

1 reference

6 November 2017

Neill R Graff-Radford

34

Neill R Graff-Radford

1 reference

6 November 2017

25

Keith A Josephs

1 reference

6 November 2017

8

Ging-Yuek R Hsiung

1 reference

6 November 2017

3

Michael G Heckman

1 reference

6 November 2017

26

Joseph E Parisi

1 reference

6 November 2017

33

Kevin B Boylan

1 reference

6 November 2017

10

Anna M Karydas

1 reference

6 November 2017

9

Heather Stewart

1 reference

6 November 2017

22

Carol Lippa

1 reference

6 November 2017

13

Eileen H Bigio

1 reference

6 November 2017

2

Bianca Mullen

1 reference

6 November 2017

14

Sandra Weintraub

1 reference

6 November 2017

15

Marsel Mesulam

1 reference

6 November 2017

16

Kimmo J Hatanpaa

1 reference

6 November 2017

Matthew C Baker

4

1 reference

6 November 2017

Patricia H Brown

6

1 reference

6 November 2017

Andrew Kertesz

12

1 reference

6 November 2017

Richard Caselli

23

1 reference

6 November 2017

Ian R Mackenzie

29

1 reference

6 November 2017

2 May 2014

1 reference

6 November 2017

Neurobiology of Aging

1 reference

6 November 2017

35

1 reference

6 November 2017

10

1 reference

6 November 2017

2421.e13-7

1 reference

TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

C9ORF72 repeat expansions in cases with previously identified pathogenic mutations

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

De novo mutations in ataxin-2 gene and ALS risk

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Stress granules as crucibles of ALS pathogenesis.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

ATXN2 and its neighbouring gene SH2B3 are associated with increased ALS risk in the Turkish population

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

SMN1 gene duplications are associated with sporadic ALS.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Ataxin-2 repeat-length variation and neurodegeneration

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Ataxin-2 intermediate-length polyglutamine expansions in European ALS patients

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

ATXN2 CAG repeat expansions increase the risk for Chinese patients with amyotrophic lateral sclerosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Ataxin-2 polyQ expansions in FTLD-ALS spectrum disorders in Flanders-Belgian cohorts.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

The modulation of Amyotrophic Lateral Sclerosis risk by ataxin-2 intermediate polyglutamine expansions is a specific effect

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Ataxin-2 intermediate-length polyglutamine: a possible risk factor for Chinese patients with amyotrophic lateral sclerosis.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

SMN1 gene, but not SMN2, is a risk factor for sporadic ALS

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4105839

NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis

1 December 2018

1 reference

12 December 2020

Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease

1 reference

12 December 2020

Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS

1 reference

12 December 2020

SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS

1 reference

12 December 2020

ALS risk but not phenotype is affected by ataxin-2 intermediate length polyglutamine expansion

1 reference

12 December 2020

Association of Long ATXN2 CAG Repeat Sizes With Increased Risk of Amyotrophic Lateral Sclerosis

1 reference

12 December 2020

ATXN-2 CAG repeat expansions are interrupted in ALS patients

1 reference

12 December 2020

Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis

1 reference

12 December 2020

10.1016/J.NEUROBIOLAGING.2014.04.016

Identifiers

DOI

1 reference

6 November 2017

1 reference

6 November 2017

1 reference